Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Obici

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
Arquivos De Neuro-Psiquiatria|October 27, 2018
Becoming familiar with hereditary transthyretin amyloidosis, a treatable neuropathyLaura Obici
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 21, 2019
Light Chains With Heavy EffectsLaura Obici, Giampaolo Merlini
Journal of the Peripheral Nervous System : JPNS|May 8, 2020
Acquired and inherited amyloidosis: Knowledge driving patients' careLaura Obici, David Adams
Mayo Clinic Proceedings|November 6, 2018
Seek and You Shall Find: Is Subclinical Amyloid More Common Than Expected?Laura Obici, Giampaolo Merlini
Autoimmunity Reviews|August 11, 2012
Amyloidosis in autoinflammatory syndromesLaura Obici, Giampaolo Merlini
Swiss Medical Weekly|June 2, 2012
AA amyloidosis: basic knowledge, unmet needs and future treatmentsLaura Obici, Giampaolo Merlini
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 1, 2021
Current and Emerging Therapies for Hereditary Transthyretin Amyloidosis: Strides Towards a Brighter FutureLaura Obici, Roberta Mussinelli
Expert Opinion on Investigational Drugs|July 9, 2014
An overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosisLaura Obici, Giampaolo Merlini
Clinical and Experimental Rheumatology|May 10, 2018
Renal involvement in autoinflammatory diseases and inflammasome-mediated chronic kidney damageRoberto Scarpioni, Laura Obici
Kidney International|January 23, 2022
AA amyloidosis without systemic inflammation: when clinical evidence validates predictions of experimental medicineLaura Obici, Vittorio Bellotti
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Arquivos De Neuro-Psiquiatria|October 27, 2018
Becoming familiar with hereditary transthyretin amyloidosis, a treatable neuropathyLaura Obici
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 21, 2019
Light Chains With Heavy EffectsLaura Obici, Giampaolo Merlini
Journal of the Peripheral Nervous System : JPNS|May 8, 2020
Acquired and inherited amyloidosis: Knowledge driving patients' careLaura Obici, David Adams
Mayo Clinic Proceedings|November 6, 2018
Seek and You Shall Find: Is Subclinical Amyloid More Common Than Expected?Laura Obici, Giampaolo Merlini
Autoimmunity Reviews|August 11, 2012
Amyloidosis in autoinflammatory syndromesLaura Obici, Giampaolo Merlini
Swiss Medical Weekly|June 2, 2012
AA amyloidosis: basic knowledge, unmet needs and future treatmentsLaura Obici, Giampaolo Merlini
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 1, 2021
Current and Emerging Therapies for Hereditary Transthyretin Amyloidosis: Strides Towards a Brighter FutureLaura Obici, Roberta Mussinelli
Expert Opinion on Investigational Drugs|July 9, 2014
An overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosisLaura Obici, Giampaolo Merlini
Clinical and Experimental Rheumatology|May 10, 2018
Renal involvement in autoinflammatory diseases and inflammasome-mediated chronic kidney damageRoberto Scarpioni, Laura Obici
Kidney International|January 23, 2022
AA amyloidosis without systemic inflammation: when clinical evidence validates predictions of experimental medicineLaura Obici, Vittorio Bellotti
Pageof 21